GL1X · GenesisL1 explorer

MolNFT v1 · #133128 · protein

Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z2856434942

5RM9: “Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z2856434942”. X-ray diffraction, 3 ligands (EJQ, ZN, PO4), 12 pockets (best druggability 0.79). MolNFT v1 #133128 on GenesisL1: 3D…

PDB
5RM9
Type
protein
Length
1,157 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Helicase
EC
3.6.4.12, 3.6.4.13
UniProt
P0DTD1
Ligands
EJQ, ZN, PO4
Pockets
12 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHelicase (EC 3.6.4.12, 3.6.4.13)protein57231% helix, 24% strandP0DTD1
BHelicase (EC 3.6.4.12, 3.6.4.13)protein58529% helix, 25% strandP0DTD1

Ligands and binding sites

  • EJQ · ~{N}-(4-fluorophenyl)-2-pyrrolidin-1-yl-ethanamide · ligand · chains B
  • ZN · Zinc ion · metal · 6 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19150.790.8190empty
25060.710.8147empty
33470.650.8043empty
43930.650.7939empty
52970.630.8040empty

Interfaces

1 interface between chains.

  • A–B · 646 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 5RM9 · PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.